Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients
GC Hillyer, M Beauchemin, DL Hershman… - Clinical …, 2020 - journals.sagepub.com
Background/Aims Essential to bringing innovative cancer treatments to patients is voluntary
participation in clinical trials but approximately 8% of American cancer patients are enrolled …
participation in clinical trials but approximately 8% of American cancer patients are enrolled …
[PDF][PDF] Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients
GC Hillyer, M Beauchemin, DL Hershman… - Clinical …, 2020 - researchgate.net
Abstract Background/Aims: Essential to bringing innovative cancer treatments to patients is
voluntary participation in clinical trials but approximately 8% of American cancer patients are …
voluntary participation in clinical trials but approximately 8% of American cancer patients are …
Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients
GA Hillyer, M Beauchemin, DL Hershman… - 2020 - academiccommons.columbia.edu
Background/aims: Essential to bringing innovative cancer treatments to patients is voluntary
participation in clinical trials but approximately 8% of American cancer patients are enrolled …
participation in clinical trials but approximately 8% of American cancer patients are enrolled …
[PDF][PDF] Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients
GC Hillyer, M Beauchemin, DL Hershman, M Kelsen… - Clinical Trials, 2020 - academia.edu
Abstract Background/Aims: Essential to bringing innovative cancer treatments to patients is
voluntary participation in clinical trials but approximately 8% of American cancer patients are …
voluntary participation in clinical trials but approximately 8% of American cancer patients are …
[HTML][HTML] Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients
GC Hillyer, M Beauchemin, DL Hershman… - Clinical trials (London …, 2020 - ncbi.nlm.nih.gov
Methods: Physicians (MD, DO, fellows, residents) and research staff (physician assistants,
nurse practitioners, staff and research nurses, clinical assistants, and program coordinators) …
nurse practitioners, staff and research nurses, clinical assistants, and program coordinators) …
Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
GC Hillyer, M Beauchemin, DL Hershman… - Clinical Trials …, 2020 - europepmc.org
Methods Physicians (MD, DO, fellows, residents) and research staff (physician assistants,
nurse practitioners, staff and research nurses, clinical assistants, and program coordinators) …
nurse practitioners, staff and research nurses, clinical assistants, and program coordinators) …
Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients
GC Hillyer, M Beauchemin… - Clinical trials …, 2020 - pubmed.ncbi.nlm.nih.gov
Background/aims Essential to bringing innovative cancer treatments to patients is voluntary
participation in clinical trials but approximately 8% of American cancer patients are enrolled …
participation in clinical trials but approximately 8% of American cancer patients are enrolled …
Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
GC Hillyer, M Beauchemin, DL Hershman… - Clinical Trials …, 2020 - europepmc.org
Methods Physicians (MD, DO, fellows, residents) and research staff (physician assistants,
nurse practitioners, staff and research nurses, clinical assistants, and program coordinators) …
nurse practitioners, staff and research nurses, clinical assistants, and program coordinators) …